Invited Speakers

Professor Rooma Sinha is a global pioneer and Chief Gynecologist at Apollo Hospital, Hyderabad.
Since introducing robotic surgery to India in 2012, she has become the nation’s foremost expert in treating benign gynecological conditions and uterine fibroids. A visionary leader, she is the Founder President of the Association of Gynecological Robotic Surgeons of India (AGRS), President-Elect of the Asian Society of Gynecological Robotic Surgeons (ASGRS), and is SERGS-certified in Europe.
Beyond her surgical mastery, Dr. Sinha is a dedicated mentor, directing the prestigious MARS and Vattikuti fellowship programs to train the next generation of specialists. Please join me in welcoming a true leader at the forefront of surgical innovation.

Dr. Jiheum Paek is a leader in minimally invasive surgical techniques and one of the most experienced gynecologic robotic surgeons in Asia as well as Korea. He has extensive experience in treating gynecologic cancer as well as complex benign disease. He has performed more than 2,100 cases of robotic surgery and 2,000 cases of single-port laparoscopic surgery in the gynecologic field. Dr. Paek completed Gynecologic Oncology fellowship at Yonsei University Severance Hospital and joined Dr. Peter Lim’s robotic surgery and clinical research program at University of Nevada, Reno, USA as a visiting scholar. He is currently a Professor and the Director of the Robotic Surgery Center at Ajou University Hospital, Korea. He is President-elect as well as one of the founding members of the Asian Society of Gynecologic Robotic Surgery. He currently serves as the Publication Committee Chair of the Society of Korean Robotic Gynecologic Surgery and International Planning Committee Chair of the Korean Society of Gynecologic Endoscopy.

Professor Hung-Cheng Lai is a globally recognized leader and pioneer in gynecologic oncology and robotic surgery, with a career spanning over two decades of expertise in robotic-assisted surgical systems. He currently serves as the President of the Taiwan Society of Gynecologic Robotic Surgery (TSGRS) and is a former President of the Asian Society of Gynecologic Robotic Surgery (ASGRS).

Professor Lai holds prestigious academic appointments as a Professor at Taipei Medical University and the National Defense Medical University. His clinical practice is defined by his mastery of the da Vinci surgical system, particularly in the management of complex gynecologic diseases, ranging from advanced malignant tumors to intricate benign conditions and pelvic reconstruction.

TJ Kim graduated from Seoul National University College of Medicine. He completed his internship, residency and oncologic fellowship training at Samsung Medical Center, Sungkyunkwan University School of Medicine. He was awarded as ‘the best clinical fellow of the year’ in Samsung Medical Center in 2006. He is now a professor there.

TJ Kim has interests in clinical trials concerning innovative MIS (Robot, NOTES, SPA/LESS), ovarian cancer prevention and chemotherapy. He started single-port laparoscopy, hybrid NOTES, and da Vinci robotic surgery in 2008. He is the first surgeon who started single-port laparoscopy, single-site da Vinci surgery in South Korea. He has led single institutional and multi-institutional randomized clinical trials in minimally invasive surgical field. He has published more than 230 peer-reviewed international journal articles (SCI(E)) in the field of gynecologic oncology as well as minimally invasive surgery (MIS). His published articles on single-port surgery were the most cited.

TJ Kim has been an invited lecturer at international symposia and conferences as an honored guest speaker. He has also performed live demonstration surgeries in many countries. He has run observational program for foreign doctors. Many surgeons from Japan, Hong Kong, Taiwan, Singapore, India, Malaysia, Thailand, and USA visited him to observe his surgical techniques.

Department of Obstetrics and Gynecology,
Iwate Medical University School of Medicine
Deputy Director of Iwate Medicial University Hospital

Tsukasa Baba, MD, PhD, is Professor and Chair of Obstetrics and Gynecology at Iwate Medical University, Japan. A gynecologic oncologist specializing in minimally invasive and robotic surgery, he chairs the FIGO Committee on Minimal Access Surgery and promotes MIS education across the World.

Dr. Hiroaki Komatsu is a leading expert in Gynecologic Oncology and Robotic Surgery. An International Class B Robo Doc, he is a certified Proctor for the da Vinci, Hugo™ RAS, and hinotori systems. He serves as the Secretary General of the Japanese Society of Gynecologic Robotic Surgery (JSGRS) and is the Associate Editor of the Journal of Obstetrics and Gynaecology Research. His work focuses on robotic surgical education and certification systems.

Dr. Takashi Takeda is an Assistant Professor in the Department of Obstetrics and Gynecology at Keio University School of Medicine, Japan, where he earned both his M.D. and Ph.D. From 2022 to 2025, he served as a Visiting Research Fellow at the University of Oxford, supported by the Japan Society for the Promotion of Science. His research focuses on the mechanisms of ovarian cancer carcinogenesis and their clinical implications.  A dedicated leader in surgical education, Dr. Takeda founded the ARISING-GYN project, an Asia-wide initiative aimed at advancing structured education in robotic gynecologic surgery. He also collaborates with the Society of European Robotic Gynaecological Surgery (SERGS) on international training initiatives.
Dr. Takeda is board-certified in Gynecologic Oncology, Endoscopic Surgery, and Clinical Genetics in Japan. His contributions have been recognized with the Best Presentation Award (2024) and the Early Career Award (2025) from the Asian Society for Gynecologic Robotic Surgery (ASGRS). He remains active in numerous international societies, including IGCS, ASGO, and APAGE.

Prof. Ka-Yu Tse is a Clinical Professor in the Department of Obstetrics and Gynaecology at The University of Hong Kong, Honorary Consultant at Queen Mary Hospital, and Chair of the Department of Gynaecology at HKU-Shenzhen Hospital. She completed her specialized gynaecological oncology training at Queen Mary Hospital and Addenbrooke’s Hospital (Cambridge, UK) and has served as a visiting scholar at prestigious institutions, including Memorial Sloan Kettering Cancer Center.
An influential leader in her field, Prof. Tse currently serves as President of the Obstetrical and Gynaecological Society of Hong Kong (OGSHK) and Vice President of the Hong Kong Society of Gynecological Oncology (HKSGO). Internationally, she chairs the Gynaecological Oncology Committee for the Asia & Oceania Federation of Obstetrics & Gynaecology (AOFOG) and is a member of the FIGO Oncology Committee.
Prof. Tse is a dedicated researcher and editor for several peer-reviewed journals. Her clinical and research expertise focuses on surgical and medical treatments, biomarkers, and novel therapies for gynecologic cancers.

Dr. Kiyoshi Kanno is Deputy Director of the Department of Obstetrics and Gynecology at Kurashiki Medical Center, Japan, one of the country’s leading high-volume centers for minimally invasive gynecologic surgery. He specializes in laparoscopic and robotic surgery, gynecologic oncology, and advanced surgical management of deep endometriosis.
Dr. Kiyoshi Kanno has particular expertise in nerve-sparing pelvic surgery and robotic techniques using the da Vinci platform, including the development and clinical application of nerve-plane–sparing approaches and fluorescence-guided surgery with indocyanine green. His work focuses on improving surgical precision and functional outcomes in complex pelvic procedures, especially in patients with severe deep endometriosis.
He serves as an Editorial Board member of Journal of Robotic Surgery and is a Video Faculty member of the International School of Surgical Anatomy (ISSA), Italy. His surgical videos and research presentations have received numerous awards from societies such as APAGE, JSGOE, JSES, and the Japan Robotic Surgery Society.

I earned my Ph.D. from the Postgraduate School of Medicine at The Catholic University of Korea in 2005. Prior to that, I completed my M.S. at the same institution in 1999 and my M.D. in 1995.
Since 2017, I have been serving as a Professor in the Department of Obstetrics & Gynecology at Seoul St. Mary’s Hospital, The Catholic University of Korea. In 2007, I completed a postdoctoral fellowship in the Department of Experimental Therapeutics at the University of Texas, MD Anderson Cancer Center.
In addition to my academic roles, I hold several key positions and memberships. I am the Director of Department of Obstetrics and Gynecology and the Chief of the Gynecologic Cancer Center at Seoul St. Mary’s Hospital. I also serve as the immediate president of both the Korean Society of Single Port Surgery (K3S) and the Korean Society of Psychosomatic Obstetrics and Gynecology (KSPOG), and the vice president of Korean Gynecologic Oncology Group. Previously, I was the founder president of the Korean Society of Neuropelveology (KSON). Additionally, I am a Board Member of the Asian Society of Gynecologic Robotic Surgery and the past Editor-in-Chief of the GRS (Gynecologic Robotic Surgery), the official journal of both the Korean Society of Gynecologic Robotic Surgery and the Asian Society of Gynecologic Robotic Surgery.

Dr. Hakyun Chang (James) is a gynecologic oncologist at Ewha Womans University Seoul Hospital in Seoul, Korea. He specializes in minimally invasive gynecologic oncology, with a particular focus on Sinlge Port (SP) robotic surgery. Dr. Chang has extensive experience in advanced robotic procedures for gynecologic cancers and complex pelvic diseases. He is actively involved in international academic societies and has delivered numerous invited lectures on robotic and minimally invasive surgery. His research interests include robotic surgical innovation, advanced pelvic surgery, and translational research in gynecologic oncology.

Dr. Chiheum Cho is a Professor in the Department of Obstetrics and Gynecology at Keimyung University Dongsan Hospital, School of Medicine, Republic of Korea. His primary research interests focus on gynecologic oncology, particularly strategies to overcome chemoresistance in ovarian cancer and the medical treatment of uterine fibroids.
Dr. Cho began performing gynecologic laparoscopic surgery in 1992 and has since accumulated extensive surgical experience in the management of both benign and malignant gynecologic diseases. In 2011, he introduced robotic surgery into gynecologic practice at his institution. Since 2014, he has specialized in single-port robotic surgery and has performed more than 2,600 cases for a wide spectrum of gynecologic benign and malignant conditions.
He is a pioneer in the field of robotic surgery in gynecology. Dr. Cho founded the Korean Society of Gynecologic Robotic Surgery and served as President of the Asian Society of Gynecologic Robotic Surgery from 2021 to 2023.
In addition to his clinical and academic contributions, Dr. Cho has played significant leadership roles in hospital administration. He served as Director of Strategic Planning beginning in 2014 and subsequently held the positions of Hospital Director and President of the Keimyung University Dongsan Medical Center until February 2026.
Dr. Cho continues to contribute to the advancement of minimally invasive gynecologic surgery and translational research in gynecologic oncology.

Board Member, Asian Society of Gynecologic Robotic Surgery (ASGRS)
Professor Hiroaki Kobayashi is a globally recognized leader in gynecologic oncology and a pioneer in robotic surgery. A graduate of Kyushu University, he earned his Ph.D. in 1991 before completing a prestigious postdoctoral fellowship at the Sunnybrook Health Science Centre in Toronto, Canada. Currently serving as Professor and Chairman of the Department of Obstetrics and Gynecology at Kagoshima University, he also leads the Robotic Surgery Center at Munakata Suikokai General Hospital as of 2026.

With a career defined by clinical excellence and administrative leadership, Prof. Kobayashi previously served as Vice Director of Kagoshima University Hospital and Director of its Robotic Surgery Center (2020–2025). His influence extends across major international and domestic academic societies; he is the President of the Japan Society of Gynecologic Robotic Surgery (JSGRS) and a Director of the Japan Robotic Surgery Society (J-ROBO).

On the international stage, Prof. Kobayashi serves as a Director of the American Society for Gynecologic Robotic Surgery (ASGRS) and was the Congress Chair for the ASGRS 2025 meeting. As an expert in gynecologic oncology, he has chaired the Cervical Cancer Committee for the Japan Clinical Oncology Group (JCOG) and served as the Congress Chair for the Japanese Society of Gynecologic Oncology (JSGO) in 2024. His profound contributions to medical education and research have been recognized with numerous honors, including the Kanzawa Medical Research Foundation Award.

Dr. Urmila Soman is a pioneering Robotic and Laparoscopic Gynaecologist with over 23 years of experience in advanced minimally invasive surgery. Currently the Senior Consultant and Lead at Aster Medcity, Kochi, and Cluster Head for Aster Hospitals, Kerala, she has redefined surgical standards in India through innovation and clinical excellence.

A true trailblazer, Dr. Soman is the first surgeon in India accredited as a Master Surgeon in Robotic Surgery by the SRC. Her global standing is further evidenced by her 2024 SERGS Certification. Her career is marked by several “national firsts,” including India’s first robotic neovaginal construction and robotic correction of pelvic arteriovenous malformations.

Recognized for exceptional speed and precision, Dr. Soman completed 100 and 200 robotic surgeries in record time, reaching 300 cases within just two years. Beyond surgery, she is a dedicated mentor, serving as a proctor and leading an ICOG-accredited training centre. Her research is widely published, and her contributions have earned prestigious accolades, including the Vattikuti Scholar Award, AGRS Champion Award, and the KFOG Pacesetter Award. Dr. Soman continues to lead the evolution of gynecological care through surgical innovation and superior patient outcomes.

Dr Kung-Liahng Wang is the professor and honorary attending doctor of  MacKay Memorial Hospital (MMH), Taipei, Taiwan. He currently also serves as the  Professor in the Department of Obstetrics and Gynecology, Faculty of Medicine, Mackay Medical University, Taipei, Council member of the Taiwan robotic surgery association(TRSA), Council member of Taiwan society of gynecologic robotic surgery (TSGRS) and Council member of Taiwan association of gynecologic artificial intelligence and robotic surgery (TAGAIRS). He also served as Immediate Past- superintendent of Taitung Mackay Memorial Hospital (2014-2023), Immediate Past-President of the Taiwanese Gynecologic Oncology Group (TGOG)(2009-2021), Past-President of the Taiwan Association for Minimally Invasive Gynecology (TAMIG)(2016-2018), and the Past-President of both the Taiwan Association of Gynecologic Oncologists and The Society of Gynecologic Oncology, R.O.C. between 2008 and 2010.

Dr Wang received his MD at Kaohsiung Medical University in 1980 and completed his residency training at MMH. He further undertook gynecologic oncology fellowship training in 1990-91 at the M.D. Anderson Cancer Center, Houston, Texas. He also completed his management training program in 2000-2002 at the Institute of Hospital and Health Care Administration of National Yang-Ming University, Taiwan.

Dr Wang has published over 100 papers in peer reviewed journals. He also serves as the Editorial Board of the Journal of the Taiwan Society of Obstetrics and Gynecology (since 2000), International Journal of Gerontology (since 2007), Taiwan Medical Journal (since 2007), and Journal of the Society of Gynecologic Oncology, R.O.C. (since 1991). He has also been invited as a reviewer for a number top ranking journals such as Annals of Oncology, Gynecologic Oncology, and Fertility and Sterility etc.

Professional Interests and Specialties:

1. Gynecologic oncology
2. Robotic surgery
3. New diagnostic tool development
4. Cancer chemotherapy and immunotherapy
5. Minimally invasive surgeries in gynecologic oncolog

Dr. Li is a Taiwan-based gynecologist and Director of the Gynecologic Robotic & Minimally Invasive Surgery Center at Shin Kong Wu Ho-Su Memorial Hospital in Taipei.

He specializes in advanced minimally invasive techniques, including Da Vinci robotic surgery, single-port procedures, and robotic-assisted vNOTES (transvaginal natural orifice transluminal endoscopic surgery). With experience of more than 800 robotic gynecologic cases—including over 180 robotic-assisted vNOTES and 170 single-port robotic surgeries—Dr. Li is recognized for managing complex conditions such as Huge fibroids and uterus, endometriosis, and ovarian tumors using precision, scar-minimizing approaches that enhance recovery and patient outcomes.

He is deeply committed to medical education and surgical training, actively mentoring the next generation of surgeons, and is passionate about innovation, continuously advancing new techniques and integrating cutting-edge technologies to improve women’s healthcare.

He has been a gynecologist for 30 years in China. He devotes himself in clinical and basic research in gynecologic tumor. He is good at performing minimally invasive surgery for gynecologic benign/malignancies. In September 2016, he performed the first robotic surgery in gynecology field in GuangXi Province of China. Till now, he completed more than 1000 cases robotic operations without complication.

He is the board member of Asian Society for Gynecologic Robotic Surgery.

He is the Chairman of Obstetrics and Gynecology branch of Guangxi Medical Association.

He is the member of gynecologic oncology expert committee of Chinese Society of Clinical Oncology (CSCO).

Professor Yu-Fang Huang earned her medical degree from the College of Medicine at Kaohsiung Medical University, followed by residency and oncologic fellowship training at National Cheng Kung University Hospital (NCKUH). Her commitment to education has been recognized with the Excellent Teacher Award from NCKUH in 2016 and the Excellent Teacher Award from National Cheng Kung University (NCKU) from 2017 to 2019. Currently, Professor Huang serves as the Chair of Gynecologic Service and is a Full Professor in the Department of Obstetrics and Gynecology at NCKUH and NCKU College of Medicine. Advancing her leadership expertise, she is also a PhD candidate in Business Administration at NCKU. She collaborates on research initiatives with the President of National Cheng Kung University. A board member of the Taiwan Society of Gynecologic Robotic Surgery (TSGRS), Professor Huang is a pioneer in the field, having performed da Vinci robotic surgery since 2014. She specializes in multi-institutional clinical trials for gynecologic cancer and minimally invasive surgery (MIS). Her professional affiliations include TAGO, TUGA, and FUGA, with research expertise spanning gynecologic oncology, urogynecology, and advanced robotic surgery.

Professor Ling-Hung Wei is a prominent clinician-scientist specializing in gynecologic oncology at National Taiwan University (NTU). He currently leads the Gynecologic Cancer Multidisciplinary Team at National Taiwan University Hospital (NTUH) and holds executive leadership roles within the Taiwan Association of Gynecologic Oncologists and the Taiwanese Gynecologic Oncology Group. His multidisciplinary background includes an MD, a PhD in molecular toxicology, and an EMBA from NTU. Professor Wei’s research program integrates basic molecular science with clinical application, focusing on the oncogenesis of gynecological cancers. His recent pioneering work utilizes deep spatial transcriptomic profiling to map the immune landscape and heterogeneity of Ovarian Clear Cell Carcinoma. An experienced surgeon and certified instructor for Da Vinci robotic and HIFU surgery, Professor Wei has published extensively in high-impact journals, including Nature Communications and Cancer Research. His contributions have been recognized with numerous honors, most recently the International Session Award from the Japan Society of Obstetrics and Gynecology in 2023. He continues to drive progress in the field through international collaborations and clinical trial leadership.

Dr. Chun-Shuo Hsu is the Director of OB/GYN and the Women’s Urogynecology Center at Dalin Tzu Chi Hospital ,Chia yi , Taiwan. He serves as an Assistant Professor at Tzu Chi University and is a Board Member of the Formosa Association of Urogynecology (FAUG) and the Taiwan Association of Gynecologic Tumor Ablation (TAGTA). Clinical Observer at the Cleveland Clinic and Northside Hospital Atlanta, he specializes in pelvic reconstruction, robotic surgery, and microwave ablation.

Dr. Shih-Tien Hsu is a gynecologic oncologist and minimally invasive surgeon currently serving as Chief of the Division of Gynecologic Oncology at Taichung Veterans General Hospital. He received his MD, MS, and PhD degrees from China Medical University and has extensive experience in gynecologic oncology, robotic surgery, and translational cancer research. His academic interests include gynecologic cancer, artificial intelligence in medical imaging, and minimally invasive surgery.

Dr. Yu Chang received his medical degree from Kaohsiung Medical University in 1999. He previously served at Kaohsiung Medical University Hospital and E-Da Hospital, and currently holds the position of Vice Superintendent for Minimally Invasive Surgery at Kaohsiung Show Chwan Memorial Hospital.

His clinical expertise includes single-port laparoscopic surgery, hysteroscopic surgery, and robotic-assisted surgery using the da Vinci Surgical System. Dr. Chang has been dedicated to the advancement and promotion of minimally invasive gynecologic surgery throughout his career.

He has played a key role in establishing da Vinci surgical teams at three different hospitals. In 2013, he successfully established a da Vinci team at Kaohsiung Medical University Hospital; in 2017, he helped establish the da Vinci program at E-Da Hospital; and in 2025, he successfully led the development of the da Vinci surgical team at Kaohsiung Show Chwan Memorial Hospital. Under his leadership, the hospital exceeded 100 robotic-assisted surgical cases within its first year after opening, demonstrating outstanding clinical expertise and team leadership.

Dr. Chang currently also serves as the Vice Director of Taiwan IRCAD, where he is responsible for organizing and overseeing minimally invasive gynecologic surgery training programs and educational courses.

Dr. Lou Sun is an attending physician in the Department of Obstetrics, Gynecology and Women’s Health at Taichung Veterans General Hospital. She currently serves as Deputy Secretary-General of the Taiwan Society of Gynecologic Robotic Surgery (TSGRS).

Dr. Sun is board-certified in obstetrics and gynecology, minimally invasive gynecology, and gynecologic oncology in Taiwan. She has gained international observational experience at Sutter Health California Pacific Medical Center (CPMC), California, USA, and the Center of Hope in Reno, Nevada, USA. Her clinical interests include minimally invasive gynecologic surgery, vaginal natural orifice transluminal endoscopic surgery (vNOTES), robotic surgery, and gynecologic oncology.

She is dedicated to advancing the effective application of robotic surgery in gynecology.

As an obstetrician and gynecologist specializing in immunoendocrinology, I have extensive experience in minimally invasive and robotic surgery, particularly in managing endometriosis, uterine fibroids, and reproductive disorders. I am proficient in laparoscopic and hysteroscopic techniques to optimize clinical outcomes with reduced complications. Additionally, I have undergone robotic surgery training to enhance precision in complex gynecologic procedures. My commitment lies in advancing surgical innovations to improve patient care and contribute to the development of modern gynecologic surgery.

Dr. Tzu-I Wu is the Director of the Department of Obstetrics and Gynecology and head of division of Gynecology at Wanfang Hospital, Taipei Medical University. With extensive clinical experience, Dr. Wu specializes in gynecologic oncology, and she is an expert in minimally invasive surgery, specifically in colposcopy, hysteroscopy, laparoscopy and da Vinci Robotic surgery. Her research interests focus on molecular cancer biology, translational research, and the application of comprehensive surgical and medical therapy in gynecologic cancer. In 2025, Dr. Wu’s commitment to clinical excellence and patient safety was recognized with the Healthcare Excellence Gold Medal at the National Healthcare Quality Awards (NHQA) in Taiwan. Dr. Wu is a dedicated leader in the academic community, currently serving as a Board Member of the Asian Society of Gynecologic Robotic Surgery (ASGRS), the Taiwan Association of Gynecologic Oncologists and the Taiwan Gynecologic Oncology Group (TGOG). Throughout her career, she has authored numerous peer-reviewed publications in prestigious journals such as Journal of Clinical Oncology and Gynecologic Oncology, contributing significantly to the field of gynecologic cancer diagnostics and surgical outcomes.

Dr. Yi-Chen Chuang, a leading figure in minimally invasive surgery in Taiwan. Currently a director of minimally invasive gynecologic surgery at Far Eastern Memorial Hospital, and an Attending Physician at National Taiwan University BioMedical Park Hospital. Dr. Chuang has completed prestigious clinical da Vinci fellowships at the Mayo Clinic and Yale University. A pioneer in the field, he is renowned for his expertise in more than 1500 Da Vinci Robotic-assisted surgeries and 5000 advanced laparoscopic surgeries. His work has significantly advanced surgical outcomes for complex conditions such as deep infiltrating endometriosis, endometrial cancer and uterine prolapse.

He is one of the founding members of the Taiwan Robotic Surgery Association and Taiwan Society of Gynecologic Robotic Surgery. Serves on the Board of Directors of Taiwan endometriosis society, Taiwan Society for Fertility Preservation. He currently serves as a reviewer of Asian Journal of Surgery and Formosan Journal of Surgery.

Dr. Law is an Associate Professor in the Department of Post-Baccalaureate Medicine at National Chung Hsing University and the Director of the Department of Obstetrics & Gynecology at Tung’s Taichung Metroharbor Hospital. He specializes in advanced minimally invasive surgery, including laparoscopic surgery, operative hysteroscopy, various robotic platforms and gynecologic oncology diagnosis and management. Deeply committed to technological innovation, he is actively involved in the medical community as a council member for multiple professional societies in Taiwan.

Alongside his clinical leadership, he is dedicated to medical education and clinical research, continuously advancing surgical training and evidencebased care to improve women’s healthcare outcome.

Dr. Law is a highly experienced robotic gynecologic surgeon with extensive expertise in advanced minimally invasive surgery and a strong academic track record, having published several peer-reviewed articles in robotic and minimally invasive gynecologic surgery. He is among the few gynecologic specialists with comprehensive hands-on clinical, teaching, and proctoring experience across all three major robotic platforms — da Vinci Xi, da Vinci SP, and Hugo™.